Personalized prediction for a 68 year old man who takes Lactulose, Pregabalin, Sertraline Hydrochloride, Clarithromycin, Omeprazole (an AI-powered real world drug study)

Summary:

This is a personalized prediction of potential side effects and undetected conditions for up to one year, if you would have adverse effects. The study is created by eHealthMe based on data from the FDA.


On Sep, 23, 2025, 6,298,398 related reports were analyzed:

What are the drugs?

What are the conditions?


Potential side effects:

Acute prerenal failure
  • 13.51% for males aged 68 (±5) who have duodenitis
Altered state of consciousness
  • 5.16% for males aged 68 (±5) who have duodenitis and encephalitis
Anaemia
  • 6.78% for males aged 68 (±5) who have sciatica and duodenitis
  • 5.8% for males aged 68 (±5) who have sciatica and encephalitis
  • 5.63% for males aged 68 (±5) who have chronic sinus infection and sciatica
Confusional state
  • 5.08% for males aged 68 (±5) who have encephalitis
Convulsion
  • 5.16% for males aged 68 (±5) who have duodenitis and encephalitis
Crystal nephropathy
  • 5.16% for males aged 68 (±5) who have duodenitis and encephalitis
Death
  • 5.08% for males aged 68 (±5) who take lactulose
  • 5.08% for males aged 68 (±5) who take pregabalin
  • 5.08% for males aged 68 (±5) who take sertraline hydrochloride
  • 5.08% for males aged 68 (±5) who take clarithromycin
  • 5.08% for males aged 68 (±5) who take omeprazole
Dehydration
  • 16.22% for males aged 68 (±5) who have duodenitis
Diarrhea
  • 7.58% for males aged 68 (±5) who have chronic sinus infection and duodenitis
  • 7.1% for males aged 68 (±5) who have duodenitis and encephalitis
  • 6.34% for males aged 68 (±5) who have sciatica and duodenitis
Dizziness
  • 5.6% for males aged 68 (±5) who have sciatica and duodenitis
  • 5.4% for males aged 68 (±5) who have sciatica and encephalitis
  • 5.38% for males aged 68 (±5) who have sciatica and major depression
Drug ineffective
  • 9.88% for males aged 68 (±5) who have sciatica and encephalitis
  • 9.29% for males aged 68 (±5) who have sciatica and duodenitis
  • 9.26% for males aged 68 (±5) who have sciatica and major depression
  • 9.2% for males aged 68 (±5) who have major depression and encephalitis
  • 9.03% for males aged 68 (±5) who have duodenitis and encephalitis
  • 8.71% for males aged 68 (±5) who have duodenitis and major depression
  • 8.13% for males aged 68 (±5) who have chronic sinus infection and sciatica
  • 7.86% for males aged 68 (±5) who have chronic sinus infection and major depression
  • 5.73% for males aged 68 (±5) who have chronic sinus infection and encephalitis
Drug-induced liver injury
  • 5.81% for males aged 68 (±5) who have duodenitis and encephalitis
Duodenitis
  • 13.51% for males aged 68 (±5) who have duodenitis
Dyspnea
  • 6.06% for males aged 68 (±5) who have chronic sinus infection and duodenitis
Encephalitis
  • 8.39% for males aged 68 (±5) who have duodenitis and encephalitis
Fatigue
  • 5.16% for males aged 68 (±5) who have duodenitis and encephalitis
Fever
  • 6.09% for males aged 68 (±5) who have chronic sinus infection and encephalitis
  • 6.06% for males aged 68 (±5) who have chronic sinus infection and duodenitis
  • 5.81% for males aged 68 (±5) who have duodenitis and encephalitis
Hypomagnesaemia
  • 5.16% for males aged 68 (±5) who have duodenitis and encephalitis
Hypotension
  • 5.81% for males aged 68 (±5) who have duodenitis and encephalitis
Nausea and vomiting
  • 6.45% for males aged 68 (±5) who have duodenitis and encephalitis
  • 5.16% for males aged 68 (±5) who have sciatica and duodenitis
  • 5.05% for males aged 68 (±5) who have chronic sinus infection and duodenitis
Pneumonia
  • 11.62% for males aged 68 (±5) who have chronic sinus infection and duodenitis
  • 7.89% for males aged 68 (±5) who have chronic sinus infection and encephalitis
  • 5.13% for males aged 68 (±5) who have chronic sinus infection and sciatica
Rashes
  • 5.08% for males aged 68 (±5) who have encephalitis
Weight decreased
  • 5.59% for males aged 68 (±5) who have chronic sinus infection

Potential co-existing conditions:

Acute disseminated encephalomyelitis
  • 5.93% for males aged 68 (±5) who have encephalitis
Asthma
  • 15.66% for males aged 68 (±5) who have chronic sinus infection and duodenitis
  • 11.11% for males aged 68 (±5) who have chronic sinus infection and encephalitis
Atrial fibrillation/flutter
  • 5.05% for males aged 68 (±5) who have chronic sinus infection and duodenitis
Back pain
  • 12.39% for males aged 68 (±5) who have sciatica and duodenitis
  • 11.07% for males aged 68 (±5) who have sciatica and encephalitis
  • 10.75% for males aged 68 (±5) who have chronic sinus infection and sciatica
  • 6.04% for males aged 68 (±5) who have sciatica and major depression
Barrett's oesophagus
  • 18.92% for males aged 68 (±5) who have duodenitis
Bronchiectasis
  • 5.05% for males aged 68 (±5) who have chronic sinus infection and duodenitis
Convulsion
  • 5.08% for males aged 68 (±5) who have encephalitis
Diabetes
  • 5.75% for males aged 68 (±5) who have sciatica and duodenitis
  • 5.56% for males aged 68 (±5) who have chronic sinus infection and duodenitis
  • 5.0% for males aged 68 (±5) who have chronic sinus infection and sciatica
Duodenitis
  • 23.87% for males aged 68 (±5) who have duodenitis and encephalitis
  • 18.69% for males aged 68 (±5) who have chronic sinus infection and duodenitis
  • 5.46% for males aged 68 (±5) who have sciatica and duodenitis
Encephalitis
  • 76.13% for males aged 68 (±5) who have duodenitis and encephalitis
  • 42.29% for males aged 68 (±5) who have chronic sinus infection and encephalitis
  • 15.55% for males aged 68 (±5) who have sciatica and encephalitis
  • 11.8% for males aged 68 (±5) who have major depression and encephalitis
Encephalomyelitis
  • 5.08% for males aged 68 (±5) who have encephalitis
Gastritis
  • 5.16% for males aged 68 (±5) who have duodenitis and encephalitis
Glioblastoma
  • 5.93% for males aged 68 (±5) who have encephalitis
High blood cholesterol
  • 12.0% for males aged 68 (±5) who have chronic sinus infection and sciatica
  • 11.65% for males aged 68 (±5) who have sciatica and duodenitis
  • 10.41% for males aged 68 (±5) who have sciatica and encephalitis
  • 8.59% for males aged 68 (±5) who have chronic sinus infection and duodenitis
  • 7.22% for males aged 68 (±5) who have sciatica and major depression
  • 6.09% for males aged 68 (±5) who have chronic sinus infection and encephalitis
High blood pressure
  • 19.7% for males aged 68 (±5) who have chronic sinus infection and duodenitis
  • 18.13% for males aged 68 (±5) who have chronic sinus infection and sciatica
  • 17.7% for males aged 68 (±5) who have sciatica and duodenitis
  • 15.15% for males aged 68 (±5) who have sciatica and encephalitis
  • 13.39% for males aged 68 (±5) who have sciatica and major depression
  • 12.19% for males aged 68 (±5) who have chronic sinus infection and encephalitis
  • 11.79% for males aged 68 (±5) who have chronic sinus infection and major depression
  • 10.45% for males aged 68 (±5) who have duodenitis and major depression
  • 9.1% for males aged 68 (±5) who have major depression and encephalitis
  • 5.59% for males aged 68 (±5) who take lactulose
  • 5.59% for males aged 68 (±5) who take pregabalin
  • 5.59% for males aged 68 (±5) who take sertraline hydrochloride
  • 5.59% for males aged 68 (±5) who take clarithromycin
  • 5.59% for males aged 68 (±5) who take omeprazole
Hyperlipidaemia
  • 16.22% for males aged 68 (±5) who have duodenitis
Hypersensitivity
  • 5.05% for males aged 68 (±5) who have chronic sinus infection and duodenitis
Hypogammaglobulinaemia
  • 5.59% for males aged 68 (±5) who have chronic sinus infection
Insomnia
  • 10.1% for males aged 68 (±5) who have chronic sinus infection and duodenitis
  • 7.0% for males aged 68 (±5) who have chronic sinus infection and major depression
  • 6.86% for males aged 68 (±5) who have duodenitis and major depression
  • 5.8% for males aged 68 (±5) who have major depression and encephalitis
  • 5.38% for males aged 68 (±5) who have chronic sinus infection and encephalitis
  • 5.06% for males aged 68 (±5) who have sciatica and major depression
Major depression
  • 95.97% for males aged 68 (±5) who have duodenitis and major depression
  • 88.2% for males aged 68 (±5) who have major depression and encephalitis
  • 84.56% for males aged 68 (±5) who have chronic sinus infection and major depression
  • 57.91% for males aged 68 (±5) who have sciatica and major depression
Multiple myeloma
  • 5.19% for males aged 68 (±5) who take lactulose
  • 5.19% for males aged 68 (±5) who take pregabalin
  • 5.19% for males aged 68 (±5) who take sertraline hydrochloride
  • 5.19% for males aged 68 (±5) who take clarithromycin
  • 5.19% for males aged 68 (±5) who take omeprazole
Nasal polyps
  • 9.09% for males aged 68 (±5) who have chronic sinus infection and duodenitis
  • 6.45% for males aged 68 (±5) who have chronic sinus infection and encephalitis
Nausea
  • 13.51% for males aged 68 (±5) who have duodenitis
Neuropathy peripheral
  • 5.05% for males aged 68 (±5) who have chronic sinus infection and duodenitis
Sciatica
  • 94.54% for males aged 68 (±5) who have sciatica and duodenitis
  • 84.45% for males aged 68 (±5) who have sciatica and encephalitis
  • 80.13% for males aged 68 (±5) who have chronic sinus infection and sciatica
  • 42.09% for males aged 68 (±5) who have sciatica and major depression
Sinusitis - chronic
  • 81.31% for males aged 68 (±5) who have chronic sinus infection and duodenitis
  • 57.71% for males aged 68 (±5) who have chronic sinus infection and encephalitis
  • 20.13% for males aged 68 (±5) who have chronic sinus infection and sciatica
  • 15.44% for males aged 68 (±5) who have chronic sinus infection and major depression

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

How the study uses the data?

The study is based on gender, age, active ingredients of any drugs used, and more. Other drugs that have the same active ingredients (e.g. generic drugs) are considered.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

Related publications that referenced our studies

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe:

Recent personalized studies on eHealthMe: